Aims To improve monitoring of capillary blood sugars (CBG) and diagnosis of steroid
induced diabetes in patients receiving high dose steroids to treat a flare of inflammatory …

Background Glucocorticoids (GC) have been first-line treatment for hospitalised IBD patients
for over 60 years, despite the introduction of biologic therapy. IBD patients often have …

Background Glucocorticosteroids (GC) are long-established, widely used agents for
induction of remission in inflammatory bowel disease (IBD). Hyperglycaemia is a known …

Therapeutic drug monitoring (TDM) is the measurement of serum drug concentrations and
anti-drug-antibodies (ADA) for biologic therapies used to treat inflammatory bowel disease …

Methods We conducted a retrospective review of IBD adult patients hospitalized at a private,
not-for-profit academic hospital in southeastern New England over a 15-month period (June …

Background and Objectives: Systemic administration of glucocorticoids is a mainstay
therapy for various inflammatory diseases and may lead to hyperglycemia, which carries the …

There is a universal need to curtail healthcare expenditure [1]. Growing costs are attributed
to increased prevalence of chronic disease [2, 3]. IBD is the leading chronic disease of the …

Only a few studies of continuous glucose monitoring (CGM) in patients with steroid diabetes
have been published. Therefore, we investigated all patients with type 2 diabetes (n= 121) …

We thank Haydek and Scott for their thoughtful editorial about our PREPARE-IBD study. 1, 2
As they highlighted, there were reassuring signals regarding clinical outcomes during the …

Inflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis,
are characterized by intermittent disease flares that require unscheduled hospital visits …